Open House Original Discount Agreements 2025-01 - Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy(R))

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 101857017

  Document Type - Tender Notices

Description - Description: TK aims to conclude discount agreements with all suitable pharmaceutical companies in accordance with Section 130c Paragraph 1 of the Social Code Book V for the active ingredient combination bictegravir/emtricitabine/tenofovir alafenamid e (Biktarvy(R)). The contract is concluded as part of TK's Open House Originals procedure: Individual negotiations on contract contents are not conducted; uniform conditions apply. TK does not guarantee individual contract partners exclusivity. The contract term is a maximum of 24 months starting on March 1, 2025. The contract ends on February 28, 2027 at the latest, regardless of the date of conclusion of the contract. If the patent expires/mark

Gt Ref Id - 101857017

Deadline - Feb 28, 2027